A2ZT34 Stock Overview
Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Azenta, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$24.62 |
| 52 Week High | US$29.07 |
| 52 Week Low | US$21.34 |
| Beta | 1.47 |
| 1 Month Change | -3.83% |
| 3 Month Change | n/a |
| 1 Year Change | -6.28% |
| 3 Year Change | -35.95% |
| 5 Year Change | n/a |
| Change since IPO | -34.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| A2ZT34 | BR Life Sciences | BR Market | |
|---|---|---|---|
| 7D | -3.8% | 0% | 0% |
| 1Y | -6.3% | 0% | 0% |
Return vs Industry: A2ZT34 underperformed the BR Life Sciences industry which returned -1.8% over the past year.
Return vs Market: A2ZT34 exceeded the BR Market which returned -9.5% over the past year.
Price Volatility
| A2ZT34 volatility | |
|---|---|
| A2ZT34 Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in BR Market | 0% |
| 10% least volatile stocks in BR Market | 0% |
Stable Share Price: A2ZT34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine A2ZT34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | 3,300 | John P. Marotta | www.azenta.com |
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services.
Azenta, Inc. Fundamentals Summary
| A2ZT34 fundamental statistics | |
|---|---|
| Market cap | R$14.26b |
| Earnings (TTM) | -R$966.18m |
| Revenue (TTM) | R$3.84b |
3.7x
P/S Ratio-14.8x
P/E RatioIs A2ZT34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A2ZT34 income statement (TTM) | |
|---|---|
| Revenue | US$662.11m |
| Cost of Revenue | US$387.86m |
| Gross Profit | US$274.25m |
| Other Expenses | US$440.65m |
| Earnings | -US$166.40m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.64 |
| Gross Margin | 41.42% |
| Net Profit Margin | -25.13% |
| Debt/Equity Ratio | 0% |
How did A2ZT34 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 01:26 |
| End of Day Share Price | 2025/02/04 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Azenta, Inc. is covered by 18 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Christopher Muse | Barclays |
| Brett Hodess | BofA Global Research |
| Yuan Zhi | B. Riley Securities, Inc. |